The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades
Open accessAbstract
Background: In 2014, the Joint United Nations Programme on HIV and AIDS (UNAIDS) and partners set the ‘90-90-90 targets’; aiming to diagnose 90% of all HIV positive people, provide antiretroviral therapy (ART) for 90% of those diagnosed and achieve viral suppression for 90% of those treated, by 2020. This results in 81% of all HIV positive people on treatment and 73% of all HIV positive people achieving viral suppression. We aimed to analyse how effective national HIV treatment programmes are at meeting these targets, using HIV care continuums or cascades. Methods: We searched for HIV treatment cascades for 196 countries in published papers, conference presentations, UNAIDS databases and national reports. Cascades were constructed using reliable, generalisable, recent data from national, cross-sectional and longitudinal study cohorts. Data were collected for four stages; total HIV positive people, diagnosed, on treatment and virally suppressed. The cascades were categorised as complete (four stages) or partial (3 stages), and analysed for ‘break points’ defined as a drop >10% in coverage between consecutive 90-90-90 targets. Results: 69 country cascades were analysed (32 complete, 37 partial). Diagnosis (target one—90%) ranged from 87% (the Netherlands) to 11% (Yemen). Treatment coverage (target two—81% on ART) ranged from 71% (Switzerland) to 3% (Afghanistan). Viral suppression (target three—73% virally suppressed) was between 68% (Switzerland) and 7% (China). Conclusions: No country analysed met the 90-90-90 targets. Diagnosis was the greatest break point globally, but the most frequent key break point for individual countries was providing ART to those diagnosed. Large disparities were identified between countries. Without commitment to standardised reporting methodologies, international comparisons are complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,798
The Joint United Nations Programme on HIV/AIDS
Nygren-Krug, H. (2018) · Oxford Scholarship Online · doi:10.1093/oso/9780190672676.003.0014 · Cited by 1,950
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Musheke, M., Ntalasha, H., Gari, S., Mckenzie, O., Bond, V., Martin-Hilber, A., & Merten, S. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-220 · Cited by 429
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.
Bradley, H. M., Hall, H. I., Wolitski, R. J., Handel, M. M. V., Stone, A. E., LaFlam, M., Skarbinski, J., Higa, D. H., Prejean, J., Frazier, E. L., et al. (2014) · PubMed Central · Cited by 397
Barth, R. E., van der Loeff, M. F. S., Schuurman, R., Hoepelman, A. I., & Wensing, A. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70328-7 · Cited by 310
Barriers to access to antiretroviral treatment in developing countries: a review
Posse, M., Meheus, F., Van Asten, H., Van Der Ven, A., & Baltussen, R. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02091.x · Cited by 220
Cited by
High-quality health systems in the Sustainable Development Goals era: time for a revolution
Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., Doubova, S. V., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30386-3 · Cited by 4,057
Ekenna, A., Itanyi, I. U., Nwokoro, U., Hirschhorn, L. R., & Uzochukwu, B. (2020) · Health Policy and Planning · doi:10.1093/heapol/czaa108 · Cited by 59
Evidence-based review of statin use in patients with HIV on antiretroviral therapy
Chastain, D. B., Stover, K. R., & Riche, D. M. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.01.004 · Cited by 54
HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia
Vetrova, M. V., Cheng, D. M., Bendiks, S., Gnatienko, N., Lloyd-Travaglini, C., Jiang, W., Luoma, J., Blokhina, E., Krupitsky, E., Lioznov, D., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03172-5 · Cited by 52
Monroe‐Wise, A., Maingi Mutiti, P., Kimani, H., Moraa, H., Bukusi, D. E., & Farquhar, C. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25315 · Cited by 42
Metadata
- Authors
- Levi, J., Raymond, A., Pozniak, A., Vernazza, P., Kohler, P., & Hill, A.
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2016-09
- Volume
- 1
- Issue
- 2
- Pages
- e000010
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W2519631090
- Cited by
- 327
- References
- 32
- FWCI
- 32.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. https://app.cochat.ai/papers/10.1136/bmjgh-2015-000010
- The paper
- Levi, J., Raymond, A., Pozniak, A., Vernazza, P., Kohler, P., & Hill, A. (2016). Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Global Health. https://doi.org/10.1136/bmjgh-2015-000010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.